How B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigens.
Antibody
B cell
C1q
Cross-presentation
Dendritic cell
Fc receptor
Storage compartment
T cell
Journal
Advances in immunology
ISSN: 1557-8445
Titre abrégé: Adv Immunol
Pays: United States
ID NLM: 0370425
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
4
12
2023
pubmed:
3
12
2023
entrez:
2
12
2023
Statut:
ppublish
Résumé
In this review we discuss an underexposed mechanism in the adaptive immune system where B cell and T cell immunity collaborate. The main function of B cell immunity is the generation of antibodies which are well known for their high affinity and antigen-specificity. Antibodies can bind antigens in soluble form making so-called immune complexes (ICs) or can opsonize antigen-exposing cells or particles for degradation. This leads to well-known effector mechanisms complement activation, antibody-dependent cytotoxicity and phagocytosis. What is less realized is that antibodies can play an important role in the targeting of antigen to dendritic cells (DCs) and thereby can drive T cell immunity. Here we summarize the studies that described this highly efficient process of antibody-mediated antigen uptake in DCs in vitro and in vivo. Only very low doses of antigen can be captured by circulating antibodies and subsequently trapped by DCs in vivo. We studied the handling of these ICs by DCs in subcellular detail. Upon immune complex engulfment DCs can sustain MHC class I and II antigen presentation for many days. Cell biological analysis showed that this function is causally related to intracellular antigen-storage compartments which are functional endolysosomal organelles present in DCs. We speculate that this function is immunologically very important as DCs require time to migrate from the site of infection to the draining lymph nodes to activate T cells. The implications of these findings and the consequences for the immune system, immunotherapy with tumor-specific antibodies and novel vaccination strategies are discussed.
Identifiants
pubmed: 38042585
pii: S0065-2776(23)00030-5
doi: 10.1016/bs.ai.2023.09.002
pii:
doi:
Substances chimiques
Antigens
0
Antigen-Antibody Complex
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
37-57Informations de copyright
Copyright © 2023. Published by Elsevier Inc.